Back to Aberdeen Group plc Aberdeen Group plc

SRPTSRPT
Showing 8 of 19 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in SAREPTA THERAPEUTICS INC

Aberdeen Group plc holds 2.3M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $50.5M as of 2026-Q1. The position was increased (+3.0% shares). SRPT represents 0.1% of Aberdeen Group plc's portfolio.

Current Value

$50.5M

Current Shares

2.3M

Total Value Change

-$1.7M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.3M
+3.0%
$50.5M0.1%$15.87
30
2025-Q4
Increased
2.3M
+13.6%
$48.5M0.1%$21.49
33
2025-Q3
Increased
2M
+59.6%
$38.2M0.1%$18.82
42
2025-Q2
Increased
1.2M
+91.1%
$21.5M0.0%$17.11
45
2025-Q1
Increased
650,279
+42.1%
$41.7M0.1%$70.41
39
2024-Q4
Increased
457,695
+6.2%
$55.3M0.1%$121.19
37
2024-Q3
Increased
431,098
+30.7%
$53.9M0.1%$124.53
37
2024-Q2
Increased
329,845
+71.9%
$52.1M0.1%$158.00
44

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used